Nova Mentis Life Science (Nova Mentis Life Science) EV-to-Revenue : 76.43 (As of May. 18, 2024)

View and export this data going back to 2013. Start your Free Trial

What is Nova Mentis Life Science EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Nova Mentis Life Science's enterprise value is $1.61 Mil. Nova Mentis Life Science's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was $0.02 Mil. Therefore, Nova Mentis Life Science's EV-to-Revenue for today is 76.43.

The historical rank and industry rank for Nova Mentis Life Science's EV-to-Revenue or its related term are showing as below:

NMLSF' s EV-to-Revenue Range Over the Past 10 Years
Min: 0 Med: 0 Max: 0
Current: 76.43

NMLSF's EV-to-Revenue is ranked worse than
81.88% of 1043 companies
in the Biotechnology industry
Industry Median: 8.03 vs NMLSF: 76.43

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-18), Nova Mentis Life Science's stock price is $0.011. Nova Mentis Life Science's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $0.00. Therefore, Nova Mentis Life Science's PS Ratio for today is .

Nova Mentis Life Science EV-to-Revenue Historical Data

The historical data trend for Nova Mentis Life Science's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nova Mentis Life Science EV-to-Revenue Chart

Nova Mentis Life Science Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EV-to-Revenue

Get a 7-Day Free Trial

797.04

1,977.61

Nova Mentis Life Science Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23
EV-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	130.54

Competitive Comparison of Nova Mentis Life Science's EV-to-Revenue

For the Biotechnology subindustry, Nova Mentis Life Science's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nova Mentis Life Science's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nova Mentis Life Science's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Nova Mentis Life Science's EV-to-Revenue falls into.

Nova Mentis Life Science EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Nova Mentis Life Science's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	1.605	/	0.021
	=	76.43

Nova Mentis Life Science's current Enterprise Value is $1.61 Mil.
Nova Mentis Life Science's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.02 Mil.

Nova Mentis Life Science (OTCPK:NMLSF) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Nova Mentis Life Science's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.011	/	0
	=

Nova Mentis Life Science's share price for today is $0.011.
Nova Mentis Life Science's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

Nova Mentis Life Science EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Nova Mentis Life Science's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Nova Mentis Life Science (Nova Mentis Life Science) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nova Mentis Life Science Corp (OTCPK:NMLSF) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

HN3Q:Germany NOVA:Canada

Address

700-838 West Hastings Street, Vancouver, BC, CAN, V6C 0A6

Website

https://www.novamentis.ca

Nova Mentis Life Science Corp is a Canadian-based biotechnology company. It is engaged in developing diagnostics and psilocybin-based therapeutics for neuroinflammatory disorders. Nova uses psilocybin in the treatment of Fragile X Syndrome (FXS). The company's goal is to diagnose and treat debilitating chronic conditions that have unmet medical needs such as autism spectrum disorder (ASD) and FXS. It has one industry segment, being research and development of psilocybin, and in one geographic area, which is Canada.